Ep300 |
chromatin |
GO:0000785 |
Ep300 |
cytoplasm |
GO:0005737 |
Ep300 |
cytosol |
GO:0005829 |
Ep300 |
histone acetyltransferase complex |
GO:0000123 |
Ep300 |
host cell nucleus |
GO:0042025 |
Ep300 |
nucleoplasm |
GO:0005654 |
Ep300 |
nucleus |
GO:0005634 |
Ep300 |
protein-containing complex |
GO:0032991 |
Ep300 |
protein-DNA complex |
GO:0032993 |
Ep300 |
transcription regulator complex |
GO:0005667 |
Ep300 |
acetyltransferase activity |
GO:0016407 |
Ep300 |
activating transcription factor binding |
GO:0033613 |
Ep300 |
androgen receptor binding |
GO:0050681 |
Ep300 |
antigen binding |
GO:0003823 |
Ep300 |
beta-catenin binding |
GO:0008013 |
Ep300 |
bHLH transcription factor binding |
GO:0043425 |
Ep300 |
chromatin binding |
GO:0003682 |
Ep300 |
chromatin DNA binding |
GO:0031490 |
Ep300 |
cis-regulatory region sequence-specific DNA binding |
GO:0000987 |
Ep300 |
damaged DNA binding |
GO:0003684 |
Ep300 |
DNA binding |
GO:0003677 |
Ep300 |
glucocorticoid receptor binding |
GO:0035259 |
Ep300 |
histone acetyltransferase activity |
GO:0004402 |
Ep300 |
histone butyryltransferase activity |
GO:0140069 |
Ep300 |
histone crotonyltransferase activity |
GO:0140068 |
Ep300 |
lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0004468 |
Ep300 |
mitogen-activated protein kinase binding |
GO:0051019 |
Ep300 |
NF-kappaB binding |
GO:0051059 |
Ep300 |
nuclear hormone receptor binding |
GO:0035257 |
Ep300 |
p53 binding |
GO:0002039 |
Ep300 |
peptide butyryltransferase activity |
GO:0140065 |
Ep300 |
peptide-lysine-N-acetyltransferase activity |
GO:0061733 |
Ep300 |
peroxisome proliferator activated receptor binding |
GO:0042975 |
Ep300 |
pre-mRNA intronic binding |
GO:0097157 |
Ep300 |
promoter-specific chromatin binding |
GO:1990841 |
Ep300 |
protein antigen binding |
GO:1990405 |
Ep300 |
protein C-terminus binding |
GO:0008022 |
Ep300 |
protein kinase binding |
GO:0019901 |
Ep300 |
protein propionyltransferase activity |
GO:0061920 |
Ep300 |
protein-containing complex binding |
GO:0044877 |
Ep300 |
RNA polymerase II activating transcription factor binding |
GO:0001102 |
Ep300 |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000978 |
Ep300 |
RNA polymerase II transcription factor binding |
GO:0001085 |
Ep300 |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0000977 |
Ep300 |
SMAD binding |
GO:0046332 |
Ep300 |
STAT family protein binding |
GO:0097677 |
Ep300 |
transcription coactivator activity |
GO:0003713 |
Ep300 |
transcription factor binding |
GO:0008134 |
Ep300 |
transferase activity, transferring acyl groups |
GO:0016746 |
Ep300 |
zinc ion binding |
GO:0008270 |
Ep300 |
animal organ morphogenesis |
GO:0009887 |
Ep300 |
apoptotic process |
GO:0006915 |
Ep300 |
B cell differentiation |
GO:0030183 |
Ep300 |
behavioral defense response |
GO:0002209 |
Ep300 |
cartilage development |
GO:0051216 |
Ep300 |
cell cycle |
GO:0007049 |
Ep300 |
cellular response to UV |
GO:0034644 |
Ep300 |
circadian rhythm |
GO:0007623 |
Ep300 |
face morphogenesis |
GO:0060325 |
Ep300 |
fat cell differentiation |
GO:0045444 |
Ep300 |
heart development |
GO:0007507 |
Ep300 |
histone acetylation |
GO:0016573 |
Ep300 |
histone H2B acetylation |
GO:0043969 |
Ep300 |
histone H3 acetylation |
GO:0043966 |
Ep300 |
histone H4 acetylation |
GO:0043967 |
Ep300 |
internal peptidyl-lysine acetylation |
GO:0018393 |
Ep300 |
internal protein amino acid acetylation |
GO:0006475 |
Ep300 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO:0042771 |
Ep300 |
learning or memory |
GO:0007611 |
Ep300 |
lung development |
GO:0030324 |
Ep300 |
macrophage derived foam cell differentiation |
GO:0010742 |
Ep300 |
megakaryocyte development |
GO:0035855 |
Ep300 |
multicellular organism growth |
GO:0035264 |
Ep300 |
N-terminal peptidyl-lysine acetylation |
GO:0018076 |
Ep300 |
negative regulation of cell death |
GO:0060548 |
Ep300 |
negative regulation of cellular metabolic process |
GO:0031324 |
Ep300 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0043154 |
Ep300 |
negative regulation of gluconeogenesis |
GO:0045721 |
Ep300 |
negative regulation of miRNA metabolic process |
GO:2000629 |
Ep300 |
negative regulation of protein-containing complex assembly |
GO:0031333 |
Ep300 |
negative regulation of transcription by RNA polymerase II |
GO:0000122 |
Ep300 |
peptidyl-lysine acetylation |
GO:0018394 |
Ep300 |
peptidyl-lysine butyrylation |
GO:0140067 |
Ep300 |
peptidyl-lysine crotonylation |
GO:0140066 |
Ep300 |
peptidyl-lysine propionylation |
GO:0061921 |
Ep300 |
platelet formation |
GO:0030220 |
Ep300 |
positive regulation by host of viral transcription |
GO:0043923 |
Ep300 |
positive regulation of axon extension |
GO:0045773 |
Ep300 |
positive regulation of cell death |
GO:0010942 |
Ep300 |
positive regulation of cell growth |
GO:0030307 |
Ep300 |
positive regulation of cell growth involved in cardiac muscle cell development |
GO:0061051 |
Ep300 |
positive regulation of cell size |
GO:0045793 |
Ep300 |
positive regulation of cellular metabolic process |
GO:0031325 |
Ep300 |
positive regulation of collagen biosynthetic process |
GO:0032967 |
Ep300 |
positive regulation of DNA binding |
GO:0043388 |
Ep300 |
positive regulation of DNA-binding transcription factor activity |
GO:0051091 |
Ep300 |
positive regulation of gene expression |
GO:0010628 |
Ep300 |
positive regulation of gene expression, epigenetic |
GO:0045815 |
Ep300 |
positive regulation of glycoprotein biosynthetic process |
GO:0010560 |
Ep300 |
positive regulation of histone acetylation |
GO:0035066 |
Ep300 |
positive regulation of muscle atrophy |
GO:0014737 |
Ep300 |
positive regulation of neuron projection development |
GO:0010976 |
Ep300 |
positive regulation of NIK/NF-kappaB signaling |
GO:1901224 |
Ep300 |
positive regulation of protein acetylation |
GO:1901985 |
Ep300 |
positive regulation of protein binding |
GO:0032092 |
Ep300 |
positive regulation of protein import into nucleus |
GO:0042307 |
Ep300 |
positive regulation of protein phosphorylation |
GO:0001934 |
Ep300 |
positive regulation of protein secretion |
GO:0050714 |
Ep300 |
positive regulation of proteolysis |
GO:0045862 |
Ep300 |
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
GO:1905636 |
Ep300 |
positive regulation of sarcomere organization |
GO:0060298 |
Ep300 |
positive regulation of transcription by RNA polymerase II |
GO:0045944 |
Ep300 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response |
GO:0006990 |
Ep300 |
positive regulation of transcription, DNA-templated |
GO:0045893 |
Ep300 |
positive regulation of transforming growth factor beta receptor signaling pathway |
GO:0030511 |
Ep300 |
positive regulation of translation |
GO:0045727 |
Ep300 |
protein acetylation |
GO:0006473 |
Ep300 |
protein destabilization |
GO:0031648 |
Ep300 |
protein kinase B signaling |
GO:0043491 |
Ep300 |
protein stabilization |
GO:0050821 |
Ep300 |
protein-DNA complex assembly |
GO:0065004 |
Ep300 |
regulation of androgen receptor signaling pathway |
GO:0060765 |
Ep300 |
regulation of angiotensin metabolic process |
GO:0060177 |
Ep300 |
regulation of glycolytic process |
GO:0006110 |
Ep300 |
regulation of mitochondrion organization |
GO:0010821 |
Ep300 |
regulation of transcription by RNA polymerase II |
GO:0006357 |
Ep300 |
regulation of transcription, DNA-templated |
GO:0006355 |
Ep300 |
regulation of tubulin deacetylation |
GO:0090043 |
Ep300 |
response to calcium ion |
GO:0051592 |
Ep300 |
response to dexamethasone |
GO:0071548 |
Ep300 |
response to drug |
GO:0042493 |
Ep300 |
response to estrogen |
GO:0043627 |
Ep300 |
response to glucose |
GO:0009749 |
Ep300 |
response to hypoxia |
GO:0001666 |
Ep300 |
skeletal muscle tissue development |
GO:0007519 |
Ep300 |
somitogenesis |
GO:0001756 |
Ep300 |
swimming |
GO:0036268 |
Ep300 |
thigmotaxis |
GO:0001966 |